Matricelf Ltd (TLV:MTLF)
Israel · Delayed Price · Currency is ILS · Price in ILA 278.20
-1.50 (-0.54%)
Apr 24, 2026, 1:44 PM IDT
Matricelf Market Cap
Matricelf has a market cap or net worth of 81.36 million as of April 24, 2026. Its market cap has increased by 58.89% in one year.
Market Cap
81.36M
Enterprise Value
61.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
278.20
Market Cap Chart
Since June 20, 2021, Matricelf's market cap has increased from 62.00M to 81.36M, an increase of 31.23%. That is a compound annual growth rate of 5.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 81.80M | -46.16% |
| Dec 31, 2025 | 151.94M | 156.50% |
| Dec 31, 2024 | 59.23M | 18.14% |
| Dec 31, 2023 | 50.14M | -7.15% |
| Dec 29, 2022 | 54.00M | -47.98% |
| Dec 30, 2021 | 103.80M | 67.43% |
| Jun 20, 2021 | 62.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 495.29M |
| Geffen Residence & Renewal | 257.44M |
| Clal Biotechnology Industries | 50.66M |
| BioLineRx | 33.94M |
| Evogene | 29.17M |
| Can-Fite BioPharma | 19.82M |
| BioLight Life Sciences | 19.45M |
| XTL Biopharmaceuticals | 18.92M |